Steve Brozak is the Managing Partner and President of WBB Securities LLC, an investment bank and financial analytical firm focused on biotechnology, pharmaceutical and medical device technologies & companies. Additionally, he was a Democratic congressional candidate during 2004 American elections cycle as well as serving on Secretary of Navy’s Navy & Marine Corps Retiree Council.
Early Life and Education
Steve Brozak was born and raised in New Jersey, receiving both his Bachelors from Columbia University and MBA from University of New York. Over his career he has held positions with firms such as Alex Brown & Sons, Cowen & Dean Witter; currently as managing partner and president of WBB Securities LLC; writing articles for publications like Nature, British Medical Journal Brain Stimulation while offering commentary for ABC News and Forbes on life science issues. Steve retired Lieutenant Colonel from Marine Corps Service serving on Secretary of Navy Retiree Council and remains active member.
Steve Brozak serves as Managing Partner and President of WBB Securities, an investment banking and financial analysis firm that specializes in biotechnology, pharmaceutical, and medical device sectors. Prior to cofounding WBB Securities, Steve worked at several prominent Wall Street firms such as Alex. Brown & Sons, Cowen & Company Dean Witter Salomon Brothers.
He has published articles in several scientific journals such as Nature, British Medical Journal and Brain Stimulation; Forbes and ABC News have featured him to express his opinions on healthcare. Furthermore, Starmine ranking system and The Wall Street Journal recognized him as a top stock picker in pharmaceutical sector.
He currently sits on the Secretary of Navy’s Navy and Marine Corps Retiree Council where he focuses on healthcare and veteran issues. Additionally, he sits on AmWell’s Board of Directors; AmWell provides providers, insurers and patients access to more affordable healthcare through its telehealth platform.
Achievement and Honors
Steve Brozak is the Managing Partner of WBB Securities LLC and has consistently been recognized by StarMine Thompson Reuters and The Wall Street Journal as one of the premier research analysts in the pharmaceutical industry. At Forbes and ABC News, he regularly contributes and has spoken at industry conferences. Furthermore, he co-founded StormBio Inc, an emerging biotechnology company focused on amelioration of hypercytokinemia for which they received an SBIR grant recently. He served in the United States Marine Corps as an LTC and now sits on its Retiree Council, Columbia University’s BA and MBA degrees, and belongs to National Military Family Association as an active member.
Steve Brozak is the Managing Partner and President of WBB Securities LLC, a financial analysis firm that specializes in biotechnology, pharmaceutical, medical equipment technology & supplies and life sciences investments. Before co-founding WBB Securities he held positions with Alex Brown & Sons, Cowen & Company Dean Witter Salomon Brothers where his analyses earned accolades such as StarMine “Top Stock Picker” among Pharmaceutical Analysts as well as recognition by The Wall Street Journal “Best on the Street” Medical Equipment Supplies Category. Additionally he regularly contributes articles with Forbes and ABC News among many other media platforms.
Born in 1961, he is married with two children and holds an LTC rank from the US Marine Corps Retiree Council.
Below we present Steve Brozak’s estimated Net Worth, Monthly and Yearly Salary, Primary Source of Income, Cars and Lifestyle details derived from Wikipedia, Google, IMDb and other reputable sources.
Brozak has written for publications like Nature, The British Medical Journal and Brain Stimulation; Forbes and ABC News regularly feature his writing; plus, he speaks at life sciences industry conferences and summits.
At WBB Securities, LLC he serves as both the Managing Partner and President, while StormBio’s Chairman and CEO. Prior to co-founding WBB Securities he worked in finance at Alex Brown & Sons, Cowen & Company and Dean Witter. In 2013 StarMine awarded him as “Top Stock Picker”, while The Wall Street Journal awarded him their “Best on the Street” financial analyst for medical equipment & supplies.